HealthQ32 Bio to Report 36-Week Topline Results from Part B of SIGNAL-AA Clinical Trial of Bempikibart in Alopecia Areata on July 13, 2026
HealthBlue Earth Therapeutics announces first participant dosed in Phase 1 clinical trial investigating Actinium (²²⁵Ac) rhPSMA-10.1 Injection in metastatic castration-resistant prostate cancer
HealthAureka Releases OpenDDE, an Open-Source Drug Discovery Engine Designed to Accelerate AI-Driven Therapeutic Discovery
HealthESHRE 42nd Annual Meeting: Halving fertility treatment costs could more than double births, major global study shows
HealthAMO Pharma Announces Update on Scientific Advice for Registrational Clinical Study of AMO-02 in Congenital Myotonic Dystrophy Type 1 Following Meetings with the U.S. Food and Drug Administration, the U.K. Medicines and Healthcare products Regulatory Agency and Health Canada
HealthHelloNation Explains Dental Implant Surgery Recovery With Insights From Dental Implants Professional Dr. Steven Dodson, DMD
HealthAbbVie Announces TEPKINLY® (epcoritamab) in Combination with Lenalidomide and Rituximab is Approved by the European Commission for the Treatment of Relapsed or Refractory Follicular Lymphoma
HealthTevra Brands Introduces Vetality® Brush Free Twist + Lick™ Dental Gel for Cats: A Brush-Free Solution Designed for Today’s Fast-Growing Cat Market
HealthAdJane Reports First Clinical Validation of its OMV Vaccine Platform Inducing Mucosal Immunity in Humans
